Skip to main content
Signal8

Vivo Capital, LLC

Vivo Capital, LLC is an Investment Adviser institutional filer with the SEC under CIK 1674712, reporting 47 portfolio positions, with 22 historical 13F filings on file. Most recent reporting period: 2026-06-30.

A Form 13F reports a manager's US-listed stock and option positions only. It does not include real estate, private funds, bonds, cash or non-US holdings, so a 13F portfolio value is not the firm's total assets under management (AUM).

  • State of incorporation: CA
  • Filing type: 13F-HR
  • Latest reporting period: 2026-06-30
  • Last filed: 2026-08-14

Top 10 portfolio positions

The largest reported holdings in Vivo Capital, LLC's most recent 13F filing, ranked by reported market value.

  1. Trevi Therapeutics Inc (TRVI)
  2. Praxis Precision Medicines (PRAX)
  3. Erasca Inc (ERAS)
  4. Arrivent BioPharma Inc (AVBP)
  5. Abivax SA - ADR (ABVX)
  6. Tango Therapeutics Inc (TNGX)
  7. Corvus Pharmaceuticals Inc (CRVS)
  8. Bright Minds Biosciences Inc (DRUG)
  9. Sinovac Biotech Ltd. (SVA)
  10. Tenax Therapeutics Inc (TENX)
/